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Abstract
Background:  The World Health Organization (WHO) and partners are collaborating to
eradicate poliomyelitis. To monitor progress, countries perform surveillance for acute flaccid
paralysis (AFP). The WHO African Regional Office (WHO-AFRO) and the U.S Centers for Disease
Control and Prevention are also involved in strengthening infectious disease surveillance and
response in Africa. We assessed whether polio-eradication initiative resources are used in the
surveillance for and response to other infectious diseases in Africa.
Methods:  During October 1999-March 2000, we developed and administered a survey
questionnaire to at least one key informant from the 38 countries that regularly report on polio
activities to WHO. The key informants included WHO-AFRO staff assigned to the countries and
Ministry of Health personnel.
Results: We obtained responses from 32 (84%) of the 38 countries. Thirty-one (97%) of the 32
countries had designated surveillance officers for AFP surveillance, and 25 (78%) used the AFP
resources for the surveillance and response to other infectious diseases. In 28 (87%) countries, AFP
program staff combined detection for AFP and other infectious diseases. Fourteen countries (44%)
had used the AFP laboratory specimen transportation system to transport specimens to confirm
other infectious disease outbreaks. The majority of the countries that performed AFP surveillance
adequately (i.e., non polio AFP rate = 1/100,000 children aged <15 years) in 1999 had added 1–5
diseases to their AFP surveillance program.
Conclusions: Despite concerns regarding the targeted nature of AFP surveillance, it is partially
integrated into existing surveillance and response systems in multiple African countries. Resources
provided for polio eradication should be used to improve surveillance for and response to other
priority infectious diseases in Africa.
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Background
The polio-eradication initiative has led to the largest in-
flux of public health resources into Africa since the small-
pox-eradication campaign, comprising both human
resources and infrastructure investment [1,2]. Public
health professionals have debated the merits and demerits
of the polio-eradication initiative, regarding the priorities
of developing countries. Supporters of the initiative have
reported on the high benefit-cost ratio of eradication
[1,2]. Among the demerits cited is that polio has a lower
public health importance as compared to other infectious
diseases – many of them epidemic prone – in poor coun-
tries [1–3]. An investigation of the impact of the polio-
eradication initiative on the status of funding for routine
immunization revealed that the amount of funding for
routine immunization activities has not increased over
the years and that whether eradication funding will be
available for other public health interventions when polio
is eradicated is unclear [4]. Anecdotally reported merits
and benefits of the polio-eradication initiative have in-
cluded increased national enthusiasm and funding for Ex-
panded Programs on Immunization, enhanced
surveillance capacity for other diseases, strengthened pub-
lic health laboratory capacity, and improved epidemio-
logic skills [2]. We report the results of a survey regarding
the impact of the polio-eradication initiative on the sur-
veillance for other infectious diseases in Africa.
In 1989, the African Regional Office of the World Health
Organization (WHO-AFRO) adopted the global goal of
eradicating poliomyelitis by the year 2000, and in 1995,
member countries initiated specific polio-eradication
strategies including acute flaccid paralysis (AFP) surveil-
lance. Resources are deployed primarily through surveil-
lance officers, development of a functional regional
laboratory network, logistics, cold-chains, communica-
tions, and transportation [5–7]. To ensure that the polio
eradication strategies were efficiently and effectively im-
plemented, countries were divided into five epidemiolog-
ical blocks on the basis of geographic proximity, similarity
in infrastructure, and program needs. These country
groupings included central, eastern, southern, and west-
ern epidemiological blocks and Countries in Special Cir-
cumstances (i.e., Angola, Democratic Republic of the
Congo, Ethiopia and Nigeria) [5]. By 1999, 38 countries
regularly reported polio/AFP surveillance data to WHO-
AFRO.
In September 1998, to share resources, and improve effi-
ciency, WHO-AFRO adopted the Integrated Disease Sur-
veillance and Response (IDSR) strategy, which aims to
improve surveillance and response by integrating infec-
tious disease surveillance programs [8,9]. The IDSR strat-
egy is based on core activities and support functions that
are required to perform infectious disease surveillance, ep-
idemic preparedness, and response [1,10,11]. Core activi-
ties include case-patient detection, registration, and
confirmation; reporting, analysis, use, and feedback of da-
ta; and epidemic preparedness and response (e.g., out-
break investigations, contact tracing, and public health
interventions). Support functions include coordination,
supervision or performance evaluation, training, and re-
source-provision for infrastructure, including communi-
cation. The Centers for Disease Control and Prevention
(U. S. Department of Health and Human Services) (CDC)
provides technical and financial support to WHO-AFRO
for both IDSR and the polio-eradication initiative, along
with the U. S. Agency for International Development and
other partners.
Methods
We performed a survey to determine the impact of AFP
surveillance on the surveillance for and response to other
infectious diseases. The objectives of the survey included
describing the characteristics of AFP surveillance pro-
grams in WHO-AFRO, how surveillance activities for AFP
and other infectious diseases have been combined, the
contribution of AFP surveillance to the surveillance of
other infectious diseases, and the effect of adding surveil-
lance and response to other infectious diseases on the per-
formance of AFP surveillance. We also used the experience
of AFP surveillance programs to obtain a description of
the constraints to strengthening infectious disease surveil-
lance in Africa. We targeted the 38 countries that regularly
report AFP surveillance and polio eradication activities to
World Health Organization (WHO).
We developed, pilot-tested, and translated into French a
survey questionnaire. The questionnaire was adminis-
tered to at least one key informant per country by tele-
phone, electronic mail, and in person during December
1999-April 2000. The key informants included Ministry of
Health officials and WHO country assignees. Non-polio
AFP rates are used as an indicator of the sensitivity of AFP
surveillance programs. A sensitive AFP surveillance pro-
gram should be able to detect a background rate of >1 case
of non-polio AFP per 100,000 children aged <15 years in
any geographic area (province, country, region etc.) per
year. Non-polio AFP rates are reported monthly to WHO
and compiled annually. We abstracted data regarding
non-polio AFP rates from the WHO website [12]. Data ac-
cruing from this survey were entered and analyzed using
Epi Info version 6.04 [13].
Results
We obtained data from 32 (84%) of the 38 countries that
regularly report on polio/AFP surveillance activities in Af-
rica to WHO (Figure 1). The highest response rates were
from the southern epidemiological blocks (all nine coun-
tries) and the Countries in Special Circumstances (all fourBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/27
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countries). The lowest response rate was from the central
epidemiological block where only two of the four coun-
tries responded.
Thirty-one (97%) of the 32 countries had designated sur-
veillance officers working on AFP surveillance, with a me-
dian number of 10 per country. Twenty-seven (84%) of
the 32 countries had an annual AFP surveillance budget
ranging from $10,000 to $1.8 million (median:
$125,000). The majority AFP surveillance programs (26
[81%]) had >1 dedicated vehicles. In the majority of
countries (27 [84%]), the AFP surveillance program was
started after the general infectious disease surveillance
program.
Detection for other infectious diseases was combined
with AFP detection in 28 (90%) countries (Table 1). In 28
(90%) countries, staff from the AFP program took respon-
sibility for informing clinicians and other health practi-
tioners regarding other infectious diseases while
conducting training in AFP surveillance. Fourteen coun-
tries (44%) had used the AFP laboratory specimen trans-
portation system to transport specimens to laboratories
for confirmation other infectious disease outbreaks.
Fifteen (47%) of the 32 countries performed AFP surveil-
lance adequately (i.e., non polio AFP rate = 1/100,000
children aged <15 years) at the end of 1999 (Figure 2).
Eleven (73%) of the 15 countries that performed AFP sur-
veillance adequately had also added 2–5 diseases onto
their AFP surveillance program. Both countries that added
>5 diseases onto their AFP surveillance program per-
formed AFP surveillance inadequately.
A total of 25 (78%) of the 32 countries had combined AFP
surveillance with surveillance for other infectious diseas-
es. The most common diseases added to surveillance for
AFP were other childhood vaccine-preventable diseases:
measles in 24 (96%) and neonatal tetanus in 22 (88%).
The other diseases added to the AFP surveillance programs
tended to be epidemic-prone diseases (e.g., cholera in 17
[68%], meningitis in 16 [64%], or yellow fever in 11
[44%]), and depended on the epidemiological patterns in
the responding countries.
When the respondents were asked to illustrate major con-
tributions attributable to the AFP surveillance programs,
12 (38%) described an improvement of national disease
surveillance (Table 2). Other contributions cited were im-
proved infrastructure or resources, increased awareness re-
garding surveillance or capacity building, and increased
Figure 1
African Region WHO (AFRO) Countries Surveyed – 2000
AFRO
Responded
AFRO
Did not respond
 Eastern Mediterranean WHO RegionBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/27
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personnel for surveillance. Major constraints to general
disease surveillance that were identified included a lack of
staff to perform surveillance, a shortage or lack of funds,
lack of vehicles or fuel, lack of training, and a lack of po-
litical commitment.
Discussion
Our survey revealed that, among the African countries that
conducted AFP surveillance and reported to WHO in
1999, the majority had designated surveillance officers,
vehicles, and annual budgets. Moreover, most of the na-
tional polio eradication programs combined the surveil-
lance for and response to AFP with other infectious
diseases. Our investigation also revealed that certain
Figure 2
Effect of integration of other diseases on the performance of acute flaccid paralysis (AFP) surveillance using 1999 non polio AFP 
rates in 32 African countries
Table 1: Integration of surveillance and response for other diseases with the acute flaccid paralysis surveillance program in 32 African 
countries – 2000
Attribute n( % )
Use AFP resources for surveillance for other diseases 26 (81)
Combine detection for other diseases with AFP 28 (90)
Inform clinicians about other diseases when informing them about AFP 27 (87)
Use AFP laboratory transportation system for other diseases 14 (44)
Total 32
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countries that had prudently added other diseases to their
AFP surveillance programs were also able to perform AFP
surveillance adequately. However, the survey also indicat-
ed that additional staff, funds, and political commitment
might be required if infectious disease surveillance and re-
sponse is to improve in Africa.
AFP surveillance programs have instituted laboratory sys-
tems in countries and have formed networks between and
within countries and with WHO-AFRO by providing port-
able computers with modems, telephone/facsimile lines,
and electronic mail connections. Our survey results indi-
cated that detection and confirmation of outbreaks of oth-
er infectious diseases has been conducted by using the
resources and infrastructure of the AFP surveillance labo-
ratory network, including the specimen transportation
system. This can be further strengthened into a network of
laboratories that can support the IDSR strategy. Joint in-
formation sessions for clinicians regarding polio-AFP sur-
veillance and other diseases of public health importance
within countries are already occurring and can be
strengthened into a collaborative training effort for IDSR.
Stronger links among epidemiologists and laboratorians
are necessary to improve outbreak detection and control.
Our study determined that the majority of diseases that
are integrated into AFP programs are vaccine-preventable
diseases (e.g., measles and neonatal tetanus), indicating
an ongoing linkage with other vaccination programs and
disease-prevention activities. Other diseases included in
AFP surveillance programs were epidemic-prone diseases
(e.g., cholera and meningitis), reflecting the importance
of epidemic response in general. Among the countries that
achieved the surveillance target for AFP in 1999, the ma-
jority included 1–5 other infectious diseases in the AFP
surveillance program, indicating that the judicious addi-
tion of a few diseases to a program such as AFP surveil-
lance is feasible without adversely affecting the primary
program.
Substantial fixed costs are involved in building and main-
taining national surveillance and response systems and a
limited number of countries can afford the cost of dupli-
cative systems [14]. Other targeted and substantially fund-
ed disease control programs (e.g., HIV/AIDS, malaria,
tuberculosis) need to consider following the example of
AFP surveillance and make investments in the surveillance
and response infrastructure at the country level. Many of
these categorical programs desire improved timeliness
and completeness of district reporting and evidence-based
decision making, which can be addressed by implement-
ing IDSR activities.
To support surveillance activities as a necessary compo-
nent of disease prevention and control activities, an ur-
gent need exists to develop a consensus core set of
surveillance and response indicators that are field-tested
and that can be monitored routinely in a similar manner
to the polio indicators, in addition to the existing surveil-
lance evaluation frameworks [15,16]. These indicators can
then guide the strengthening of surveillance systems and
the integration of other diseases into targeted disease-spe-
cific programs.
Contributions that were identified and attributable to the
presence of AFP surveillance programs indicate that polio-
eradication programs have gone beyond a purely vertical
approach (i.e., disease-specific) toward one that is more
horizontal (i.e., systems development). Improvements of
infrastructure, capacity building, and provision of person-
nel can be used to develop the overall surveillance system
for infectious diseases as long as the categorical program
policies clearly support this approach. A lack of resources
(e.g., staff, funds, vehicles, or fuel) were the main con-
straints to infectious disease surveillance that were identi-
fied in the survey – interestingly, training was not
identified as a top constraint, possibly indicating that
trained personnel already exist, at least within the AFP sur-
veillance program. Managers of categorical programs are
Table 2: Major contribution of acute flaccid paralysis surveillance to surveillance for other diseases and constraints to disease 
surveillance in 32 African countries – 2000
Contribution of AFP Surveillance n (%)
Improvement of disease surveillance 12 (38)
Improved infrastructure or resources 7 (22)
Increase awareness about surveillance or capacity building 7 (22)
Increased personnel for surveillance 3 (9)
Constraints to Disease Surveillance
Lack of staff 9 (28)
Lack of funds 7 (22)
Lack of vehicles or fuel 3 (9)
Lack of training 2 (6)
Lack of political commitment 1 (3)
Total 32BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/27
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often uneasy regarding entrusting others with gathering
surveillance data that are crucial to targeting and evaluat-
ing their programs. Therefore, ongoing training monitor-
ing and periodic external evaluations should provide the
quality assurance and credibility that integrated surveil-
lance and response programs will need to reassure manag-
ers that they are basing decisions on reliable information.
This survey had a few limitations and we were unable to
obtain responses from all the targeted countries. In certain
countries, we could not contact possible respondents be-
cause of difficulties in communication, which could have
led to introduction of bias in the survey because the non-
respondents might have had substantially different an-
swers to our questions than the respondents. Another pos-
sible limitation was that respondents were reporting on
themselves and could have lacked objectivity additional-
ly, the future employment and/or career development of
the respondents may likely depend on their capacity to
support other control programs and this may have intro-
duced a bias in answering the questionnaire, although
there is no way to determine this for certain. Further, the
tool that we used did not have questions on the accepta-
bility of AFP surveillance and the feasibility of IDSR and
we also did not evaluate the cost of IDSR or the cost to
maintain and sustain the infrastructure of the polio erad-
ication initiative after polio is eradicated. We determined
the performance of the AFP surveillance programs solely
by non polio AFP rates because of the lack of widely used
surveillance and response indicators at the time of the sur-
vey, however WHO-AFRO and CDC have recently begun
work on a list of core indicators that will help monitor
and evaluate the implementation of the IDSR process.
The findings of this survey have important implications
for WHO-AFRO's initiative to improve surveillance, epi-
demic preparedness, and response in the African region.
First, polio-eradication initiative staff, financial resources,
and infrastructure can be used as one strategy to build
IDSR in Africa. Because additional funds are needed for
surveillance now and will be needed after polio is eradi-
cated, other disease-specific programs, especially those fo-
cusing on epidemic prone diseases like malaria, might
consider investing in general infectious disease surveil-
lance following the polio example. Second, as surveillance
and response capacity are developed in Africa, adding new
diseases to existing or new surveillance systems should be
on the basis of indicators of the surveillance system's ca-
pacity not to overload the surveillance system. Finally, the
cadre of new people trained in surveillance by the polio-
eradication initiative should be used for IDSR, and career
paths should be provided for them as one lasting legacy of
the poliomyelitis-eradication campaign in Africa.
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